Today marks the first day of our New £23.3m NIHR Biomedical Research Centre Funding Award.
As the respiratory theme of the NIHR Nottingham Biomedical Research Centre this new award will enable us to continue and add to our world leading research for another 5 years.
The funding, awarded by the National Institute for Health & Social Care Research (NIHR), will mean the development of new treatments for common illnesses like asthma, Irritable Bowel Syndrome, depression and arthritis will be accelerated through the NIHR Nottingham Biomedical Research Centre over the next five years.
Professor Ian Hall is the Director of the NIHR Nottingham Biomedical Research Centre explains how this funding will support vital new developments in treatments and medical technology for use in the NHS:
“This is excellent news for our patients and for every patient living with some of the most common, but also the most debilitating health conditions in the UK today.
“In the last five years the research done by the NIHR Nottingham Biomedical Research Centre has led to breakthrough treatments and diagnostics including our significant contributions to both COVID-19 and Long Covid research.
“This funding means that we will be able to find new solutions for people whose quality of life and life expectancy is significantly reduced by the impacts of mental health, respiratory, gastrointestinal, liver and musculoskeletal conditions as well as hearing loss. It will also significantly contribute to the development of Magnetic Resonance Imaging technologies for health, which is a cornerstone of our research programme in Nottingham”
The NIHR Nottingham Biomedical Research Centre (BRC) is led by internationally renowned scientists, researchers and clinicians from Nottingham University Hospitals NHS Trust and the University of Nottingham, together with expertise from Nottinghamshire Healthcare NHS Foundation Trust and a number of NHS and academic partners across the East Midlands.
More about this funding award: